BioTech Weekly - Sep 22 - Oct 05, 2025

Sources:

• AMR Drugs and Diagnostics Must Evolve in Tandem
• MEDICURE – ANNOUNCES UPDATE ON ENROLLMENT IN ITS MEND-PNPO PHASE 3 CLINICAL TRIAL AND PRESENTATION OF THE TRIAL DESIGN AND BASELINE DATA AT THE 2025 CHILD NEUROLOGY SOCIETY CONFERENCE
• Unlocking the Potential of Transcription Factors
• Kapoose Creek Bio – Partners with Terrain Life Science to Advance Study of Lead Compound KCB-100
• What Comes Next? Industry Takeaways from FDA’s Cell and Gene Therapy Listening Session
• Variational AI – Enters Collaboration with Merck to Apply Generative AI to Drug Discovery
• BIO on the American Road: Everything’s big in Texas, including biotech
• Unclogging the Downstream Bottlenecks in Bioprocessing
• Amyloidosis: Under-diagnosed disorder with serious consequences
• A Noble Pursuit: Biotech Pioneers Remembered
• Largest Genetic Map of Human Metabolism Created

Disclaimer: This podcast includes content generated with the help of large language models (LLM). Although care has been taken to ensure accuracy, LLMs can sometimes produce incorrect or misleading information. Listeners are advised to independently verify any details, provide feedback, and reach out.